Moreover, both the frequencies and absolute numbers of Fgl2−/− tumor-specific CD8+ T cells were significantly increased relative to WT tumor-specific CD8+ T cells at day 14 in the draining lymph node (Fig. 2c–e)and spleen (Fig. 2f, g) of tumor-challenged mice. This evidence concerns the gene CD8A and neoplasm.